tiprankstipranks
Sandoz price target raised to CHF 43 from CHF 36.50 at JPMorgan
PremiumThe FlySandoz price target raised to CHF 43 from CHF 36.50 at JPMorgan
1M ago
Sandoz launches generic paclitaxel formulation in the U.S.
Premium
The Fly
Sandoz launches generic paclitaxel formulation in the U.S.
1M ago
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
Premium
The Fly
Sandoz downgraded to Sector Perform from Outperform at RBC Capital
2M ago
Sandoz receives FDA approval for Enzeevu
PremiumThe FlySandoz receives FDA approval for Enzeevu
3M ago
Sandoz initiated with an Overweight at Barclays
Premium
The Fly
Sandoz initiated with an Overweight at Barclays
4M ago
Sandoz launches biosimilar Pyzchiva across Europe
Premium
The Fly
Sandoz launches biosimilar Pyzchiva across Europe
4M ago
Sandoz receives EC approval for Wyost, Jubbonti in Europe
PremiumThe FlySandoz receives EC approval for Wyost, Jubbonti in Europe
6M ago
Sandoz price target raised to CHF 38 from CHF 35 at Berenberg
Premium
The Fly
Sandoz price target raised to CHF 38 from CHF 35 at Berenberg
6M ago
Sandoz price target raised to CHF 36.50 from CHF 33.50 at JPMorgan
Premium
The Fly
Sandoz price target raised to CHF 36.50 from CHF 33.50 at JPMorgan
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100